• Medical Lead for the Clinical Development Team (CDT) to deliver Phase 3 asthma and COPD studies • Provide medical leadership and oversight for late-stage clinical trials in asthma and COPD • Develop and refine clinical strategies and Target Product Profiles (TPPs) specific to asthma and COPD • Serve as key author of late-stage clinical protocols, aligned with regulatory requirements • Author clinical and scientific content for regulatory submissions (e.g., BLA, MAA) • Oversee study design, protocol development, data review, and safety monitoring • Perform medical monitoring for late-stage studies, ensuring patient safety, protocol compliance, and data integrity • Serve as a member of the Safety Management Team (SMT) • Collaborate cross-functionally with Clinical Operations, Regulatory, Biostatistics, and Pharmacovigilance • Serve as primary medical contact for clinical sites, investigators, and CROs • Interpret clinical trial data and contribute to study reports, regulatory filings, and publications • Represent Generate at internal and external scientific and medical meetings • Engage with external experts, advisory boards, and health authorities to support program goals